Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

OmniAb (OABI) Equity Ratio (2021 - 2026)

OmniAb (OABI) reported Equity Ratio of 0.89 for Q1 2026, little changed year-over-year from 0.89 in Q1 2025, and up 0.79% on a QoQ basis from 0.89 in Q4 2025.

OmniAb (OABI) has 6 years of Equity Ratio data on file, last reported at 0.89 in Q1 2026.

  • Quarterly Equity Ratio changed 0.12% year-over-year to 0.89 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.89 (changed 0.12% YoY) and the FY2025 annual result came in at 0.89, changed 0.44% from the prior year.
  • Equity Ratio rose to 0.89 in Q1 2026 per OABI's latest filing, from 0.89 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.98 in Q3 2022 and bottomed at 0.81 in Q4 2022.
  • The 5-year median for Equity Ratio is 0.88 (2024), against an average of 0.88.
  • The widest annual swing landed in 2022, when Equity Ratio surged 3939.35%; it then slipped 15.4% in 2023.
  • Tracing OABI's Equity Ratio over 5 years: stood at 0.81 in 2022, then increased by 3.45% to 0.84 in 2023, then gained by 5.38% to 0.88 in 2024, then advanced by 0.44% to 0.89 in 2025, then climbed by 0.79% to 0.89 in 2026.
  • Per Business Quant, the three latest OABI Equity Ratio figures stand at 0.89 (Q1 2026), 0.89 (Q4 2025), and 0.9 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 0.89

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.89
Dec 31, 2025 0.89
Sep 30, 2025 0.90
Jun 30, 2025 0.89
Mar 31, 2025 0.89
Dec 31, 2024 0.88
Sep 30, 2024 0.88
Jun 30, 2024 0.87
Mar 31, 2024 0.85
Dec 31, 2023 0.84
Sep 30, 2023 0.83
Jun 30, 2023 0.82
Mar 31, 2023 0.83
Dec 31, 2022 0.81
Sep 30, 2022 0.98
Jun 30, 2022 0.96
Mar 31, 2022 0.95
Dec 31, 2021 0.77
Sep 30, 2021 -0.03
Jun 30, 2021 0.02